Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries Ltd has scheduled a Board of Directors meeting on 30/04/2026 to consider and approve the Audited Standalone Financial Results for the relevant period. This is a routine board meeting announcement as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to intimate stock exchanges about board meetings in advance. The actual financial results and any key findings will be disclosed separately after the meeting takes place. The document content appears limited, containing primarily an error page rather than detailed filing information.
Board meeting notices for financial results approval are routine corporate events and generally considered neutral for stock movement. The actual impact on the stock will depend on the financial performance disclosed in the results when they are published post-meeting.